Market Tracker

10/31 10:00pm ET

Celgene Corp (NASDAQ:CELG)

107.09
Data as of Oct 31
 +0.15 / +0.14%
Today’s Change
66.85
Today|||52-Week Range
109.25
+26.76%
Year-to-Date

Today’s Trading

Previous close106.94
Today’s open108.74
Day’s range106.67 - 109.25
Volume5,798,073
Average volume (3 months)4,810,618
Market cap$85.5B
Dividend yield--
Data as of 3:59pm ET, 10/31/2014

Growth & Valuation

Earnings growth (last year)+2.12%
Earnings growth (this year)+23.75%
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)+19.49%
P/E ratio56.1
Price/Sales10.78
Price/Book15.70

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca PLC+0.34+0.47%
NVONovo Nordisk A/S-1.03-2.23%
BMYBristol-Myers Squibb...-0.79-1.34%
LLYEli Lilly and Co-0.47-0.70%
Data as of 4:10pm ET, 10/31/2014

Financials

Last reporting dateOctober 23, 2014
EPS forecast (this quarter)$0.96
Annual revenue (last year)$6.5B
Annual profit (last year)$1.4B
Net profit margin22.36%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert J. Hugin
President &
Chief Operating Officer
Mark J. Alles
Corporate headquarters
Summit, New Jersey

Forecasts